| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8724863 | Clinical Gastroenterology and Hepatology | 2018 | 9 Pages |
Abstract
In an analysis of a database of patients who received endoscopic placement of the OIB, we found it to be safe, effective at inducing weight loss, and to reduce obesity-related comorbidities in a real-world clinical population. Rates of early removal (before 8 weeks) did not differ significantly between clinical trials and the real-world population, but were affected by use of medications.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Eric J. Vargas, Carl M. Pesta, Ahmad Bali, Eric Ibegbu, Fateh Bazerbachi, Rachel L. Moore, Vivek Kumbhari, Reem Z. Sharaiha, Trace W. Curry, Gina DosSantos, Ramsey Schmitz, Abhishek Agnihotri, Aleksey A. Novikov, Tracy Pitt, Margo K. Dunlap, Andrea Herr,